PYXS insider transaction filings

Pyxis Oncology, Inc. — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen PYXS transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-204Dupont Jakob — DirectorGrant/award (A): 46,000 (derivative) @ $0EDGAR
2026-08-144Civik Thomas — Interim CEO, DirectorGrant/award (A): 250,956 (derivative) @ $0EDGAR
2026-07-024Dupont Jakob — DirectorOption exercise (M): 35,000 @ $1.60 · Sale (S): 35,000 @ $3.06 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2026-03-254Wadhane Jitendra — Prin Fin & Acct OfficerGrant/award (A): 109,461 @ $0 · Grant/award (A): 262,635 (derivative) @ $0EDGAR
2026-03-254Palani Santhosh — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254Cline Darren S — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254HUMPHREY RACHEL — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254HUMPHREY RACHEL — DirectorSale (S): 1,400 @ $0.97 · Sale (S): 200 @ $0.97 · Sale (S): 13,896 @ $1.03EDGAR
2026-03-254Dupont Jakob — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254Metzger Michael A — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254Lewis-Hall Freda C — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-03-254FLAVIN JOHN L — DirectorGrant/award (A): 45,867 (derivative) @ $0EDGAR
2026-02-054Civik Thomas — Interim CEO, DirectorGrant/award (A): 690,131 (derivative) @ $0EDGAR
2025-04-024Wadhane Jitendra — SVP, Chief Accounting OfficerGrant/award (A): 263,782 (derivative) @ $0.98EDGAR
2025-04-024Palani Santhosh — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024Connealy Pamela Ann — CFO & COOGrant/award (A): 414,163 (derivative) @ $0.98EDGAR
2025-04-024Sullivan Lara — President ,CEO & CMO, DirectorGrant/award (A): 918,308 (derivative) @ $0.98EDGAR
2025-04-024Civik Thomas — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024Cline Darren S — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024HUMPHREY RACHEL — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024Dupont Jakob — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024Metzger Michael A — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024Lewis-Hall Freda C — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR
2025-04-024FLAVIN JOHN L — DirectorGrant/award (A): 36,979 (derivative) @ $0.98EDGAR

Recent 8-K events — Pyxis Oncology, Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial ConditionEDGAR
2026-07-028-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
EDGAR
2026-06-158-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-148-K2.02 — Results of Operations and Financial ConditionEDGAR
2026-04-308-K/A5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-03-238-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
EDGAR
2026-02-068-K9.01 — Financial Statements and ExhibitsEDGAR
2025-12-188-K7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2025-11-038-K2.02 — Results of Operations and Financial ConditionEDGAR
2025-08-148-K2.02 — Results of Operations and Financial ConditionEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PYXS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →